This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cas Lamvac (Guangzhou) Biomedical Technology Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations in Cancer Treatment: The Contributions of Li Qin
Introduction: Li Qin is a notable inventor based in Guangdong, China, recognized for his groundbreaking work in the field of biomedical technology. His innovative approach focuses on developing a drug aimed at preventing and treating brain tumors. This invention has the potential to significantly impact the lives of patients suffering from this challenging condition.
Latest Patents: Li Qin holds a patent for a drug designed for preventing and/or treating brain tumors. The patent details a formulation that comprises various components aimed at regulating immunological functions and inflammation-related factors in the body. This drug is particularly noteworthy for its ability to break through the blood-brain barrier, fully activating immunocompetence and inhibiting tumor growth. The therapeutic effects of this drug are significant, as it extends the lifespan of patients affected by brain tumors.
Career Highlights: Li Qin is associated with Cas Lamvac (Guangzhou) Biomedical Technology Co., Ltd., where he continues to contribute to advancements in medical technology. His work is characterized by a commitment to improving patient outcomes through innovative drug development.
Collaborations: Li Qin collaborates with talented professionals in his field, including Wenting Ding and Xiaoping Chen. Their combined expertise enhances the research and development efforts at their company, fostering an environment of innovation.
Conclusion: Li Qin's contributions to the field of cancer treatment through his innovative drug for brain tumors exemplify the impact of dedicated inventors in the biomedical sector. His work not only showcases the potential for scientific advancements but also highlights the importance of collaboration in achieving significant breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile